Using commercially available software to enhance breast scans done by magnetic resonance imaging (MRI) reduces the number of false positive identifications of malignant tumors and the subsequent need for biopsies, according to a new study.
A team of researchers, led by surgeons at the Kimmel Cancer Center at Jefferson in Philadelphia, has found further evidence supporting the ability of a protein to predict how well a patient with advanced pancreatic cancer will do after surgery, chemotherapy and radiation.
Mushrooms might serve as biofactories for the production of various beneficial human drugs, according to plant pathologists who have inserted new genes into mushrooms.
amfAR, The Foundation for AIDS Research, will grant almost $1.2 million for 10 new research projects aimed at increasing understanding of the social and biological factors that influence the treatment of HIV/AIDS, Dr. Rowena Johnston, amfAR?s vice president of research.
Working parents are more able to care for their chronically ill children when given greater access to federal and employer-provided time off from their jobs, according to a RAND Corporation study issued.
With the release of its inaugural double issue this June, the Journal of Aging, Humanities, and the Arts (JAHA) seeks to create a dialogue between the humanities, medical science, and the social sciences around issues of aging, according to journal editors Anne Wyatt-Brown and Dana Burr Bradley.
Why does putting our feelings into words ? talking with a therapist or friend, writing in a journal ? help us to feel better” A new brain imaging study by UCLA psychologists reveals why verbalizing our feelings makes our sadness, anger and pain less intense.
Children with weight problems are rarely managed by their family doctors, and doctors are missing a vital opportunity to redress the obesity epidemic, new research from the NSW Centre for Overweight and Obesity has found.
In what could be a breakthrough in the treatment of neurological disease, a team led by physician-scientists at NewYork-Presbyterian Hospital/Weill Cornell Medical Center has completed the first-ever phase 1 clinical trial using gene therapy to battle Parkinson’s disease.
Scientists have provided new details about how proteins used to destroy bacteria and viruses may help treat Alzheimer?s disease. Gunnar K. Gouras, associate professor of neurology and neuroscience at Weill Medical College of Cornell University, New York, and colleagues provide new insights into how these proteins, called antibodies, reduce the main hallmarks of Alzheimer?s disease and raise hopes for a vaccine against the disease.